Expert claims that America targeted Chinese Covid vaccine to eliminate competition
Date
6/24/2024 5:30:22 AM
(MENAFN) Marcello Ferrada de Noli, a Swedish epidemiology professor emeritus and former research fellow at Harvard Medical School, has asserted that the reported Pentagon-led disinformation campaign targeting China's Sinovac COVID vaccine was likely aimed at stifling competition rather than undermining vaccination efforts entirely. According to Reuters, which cited former United States military officials, the campaign operated covertly between 2020 and 2021, primarily focusing on the Philippines. Fake social media accounts purportedly posed as local individuals to criticize not only the Chinese vaccine but also related products such as test kits and face masks.
In an interview with RT, de Noli emphasized that while typical anti-vaccine campaigns aim to dissuade vaccination, the focus on Chinese and Russian vaccines appeared driven by economic rivalry. He suggested that the intent may have been to discourage the use of vaccines from these countries in order to promote those manufactured by American companies or European associates with direct ties to the United States and European Union pharmaceutical industries.
Highlighting broader implications, de Noli referenced previous instances where the United States allegedly sought to discredit vaccines from China and Russia. He cited a notable 2021 report from the United States Department of Health and Human Services, which detailed efforts by American health officials during the administration of former President Donald Trump to dissuade Brazil from purchasing the Russian-made Sputnik V vaccine.
These actions, as outlined by de Noli, underscore ongoing geopolitical competition in the global vaccine market, where strategic interests intersect with public health initiatives. The alleged disinformation campaign, according to de Noli, reflects efforts to influence vaccine procurement decisions globally, potentially shaping international health policies and preferences in vaccine distribution.
MENAFN24062024000045015687ID1108364548
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.